SEC Form 4 · accession 0001624073-17-000004
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alistair Macdonald
Officer — Chief Executive Officer · Director
Period of report
Mar 3, 2017
Accepted (ET)
Mar 6, 2017 · 7:14 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 3, 2017 | M | 8,828 | $10.57 | A | 83,296 | D | |
| Class A Common Stock | Mar 3, 2017 | S | 8,828 | $45.00 | D | 74,468 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $10.57 | Mar 3, 2017 | M | 8,828 | D | — | Aug 17, 2022 | Class A Common Stock | 8,828 | 17,656 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2016.
- F2One half of the shares subject to this option vest yearly in five equal installments beginning on August 17, 2013, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.